Nancy Lurker, President and CEO of EyePoint Pharmaceuticals, has more than 30 years of experience in the pharmaceutical industry including drug delivery technology and diagnostics. She has a proven track record of maximizing the potential of new therapies and successfully implementing innovative US and global drug launches, having worked with start-ups and Fortune 500 companies. Lurker serves on many boards across public and private companies, and advocacy organizations. As a corporate leader, she is also extremely passionate about supporting the future of STEM.